FDA Science Board Previews Device “Critical Path” R&D Opportunity List
This article was originally published in The Gray Sheet
Executive Summary
Peripheral vasculature imaging is poised to be an early beneficiary of FDA's "critical path" initiative, CDRH Office of Science & Engineering Director Larry Kessler told the agency's Science Board April 22